Two big legal cases concerning the fate of FTX founder Sam Bankman-Fried and the CFPB. We’ve got the latest developments on each. Plus, is Microsoft’s new $9B AI tool worth the hype? And the weight-loss drug boom is having major ripple effects on stocks. We’ll look at one buy and one bail as a result of the craze.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
